SCHEMBL6089775

SCHEMBL6089775

CCC(O)(CC)c1ccc2cc[nH]c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 1/20 0.47
ENPP2 Q13822 2/20 0.43
MEN1 O00255 1/20 0.43
POLB P06746 1/20 0.43
MAPK1 P28482 1/20 0.43
KMT2A Q03164 1/20 0.43
AHR P35869 3/20 0.43
CMA1 P23946 1/20 0.43
LCK P06239 3/20 0.42
TXK P42681 3/20 0.42
SYK P43405 3/20 0.42
ITK Q08881 3/20 0.42
MAOA P21397 2/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ESR1 P03372 1/20 0.40
TAS1R3 Q7RTX0 1/20 0.40
TAS1R1 Q7RTX1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8325008 0.88 USP2 (0.48) AHRLCKTXKSYKITK
SCHEMBL13930945 0.81 MEN1 (0.44) TYRENPP2MEN1POLBMAPK1
SCHEMBL10267758 0.81 MAPK1 (0.44) TYRENPP2MEN1POLBMAPK1
SCHEMBL84519 0.76 AHR (0.50) TYRENPP2MEN1POLBMAPK1
SCHEMBL18737239 0.75 MEN1 (0.42) TYRENPP2MEN1POLBMAPK1
SCHEMBL45243 0.72 KIF11 (0.65) TYRENPP2MEN1POLBMAPK1
SCHEMBL29355842 0.72 KIF11 (0.65) TYRENPP2MEN1POLBMAPK1
SCHEMBL21110227 0.70 MEN1 (0.44) TYRENPP2MEN1POLBMAPK1
SCHEMBL23815001 0.70 AHR (0.44) MAPK1AHRMAOACYP2A6USP2
SCHEMBL13930917 0.70 AHR (0.44) AHRMAOACYP2A6USP2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060235222-A1 Indole-derivative modulators of steroid hormone nuclear receptors ELI LILLY AND COMPANY (US) 2006-10-19 US disclosed
EP-1597254-A1 INDOLE-DERIVATIVE MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS Eli Lilly and Company (US) 2005-11-23 EP disclosed
WO-2004067529-A1 INDOLE-DERIVATIVE MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS ELI LILLY AND COMPANY (US) 2004-08-12 WO disclosed
WO-2004067529-A1 INDOLE-DERIVATIVE MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS ELI LILLY AND COMPANY (US) 2004-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235222-A1 Indole-derivative modulators of steroid hormone nuclear receptors NR3C2, NR5A1, MC2R TYR 3953/4885ENPP2 2063/4885MEN1 3034/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.